rs2274700

This is a synonymous variant in the CFH gene — it does not change the protein's amino acid sequence.

GWAS Catalog Trait Associations (2)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

complement factor H measurement

Sun BB et al. Genomic atlas of the human plasma proteome. Nature 558(7708):73-79 (2018)
Allele A
OR 0.37
p 2.0e-51
N 3,301
Large GWAS
European

L lactate dehydrogenase measurement

Allele A
OR
β 0.034
p 4.0e-12
N 98,585
Large GWAS
European

ClinVar annotation

Benign★★★
1 submitter12 publications

Age related macular degeneration 4; Atypical hemolytic-uremic syndrome; Basal laminar drusen; CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II; Factor H deficiency (CFHD); Hemolytic uremic syndrome, atypical, susceptibility to, 1

View on ClinVar →

Research that mentions this SNP (4)

Assessing Susceptibility to Age-Related Macular Degeneration With Genetic Markers and Environmental Factors
AssociationN=1,844Chen Y. et al.(2011)· Archives of Ophthalmology

This case-control study of 1844 unrelated white individuals examined the association between 8 SNPs in 5 genes (CFH, HTRA1/LOC387715, C2, CFB, C3) and advanced age-related macular degeneration (AMD), including geographic atrophy and choroidal neovascularization. All genetic variants showed strong associations with AMD, with odds ratios ranging from 0.44 (C2 rs9332739, protective) to 10.99 (HTRA1/LOC387715 rs10490924 TT). A combined predictive model including genetic variants and environmental factors (smoking, age, BMI) achieved 78.8% discrimination accuracy with ROC curve AUC of 0.82.

Traits studied:Age-related macular degenerationChoroidal neovascularizationGeographic atrophy
Genetic Predictors of Response to Photodynamic Therapy
ReviewFrancesco Parmeggiani et al.(2011)· Molecular Diagnosis &amp; Therapy

Comprehensive review evaluating SNPs as genetic predictors of choroidal neovascularization (CNV) response to photodynamic therapy with verteporfin (PDT-V). The paper examines pharmacogenetic correlations for thrombo-coagulative pathway variants (MTHFR rs1801133, F5 rs6025, F2 rs1799963, F13A1 rs5985), complement/inflammatory variants (CFH, HTRA1, CRP, ARMS2), and VEGFA variants (rs699947, rs2146323), concluding that specific SNPs show clinical plausibility as markers to optimize PDT-V efficacy and guide therapeutic approaches in neovascular macular degeneration.

Traits studied:Age-related macular degeneration (AMD)Choroidal neovascularization (CNV)Neovascular macular degenerationPathologic myopia (PM)Photodynamic therapy response
Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene
AssociationN=8,000Lars G. Fritsche et al.(2009)· Human Mutation

This cumulative PhD dissertation investigates genetic susceptibility factors for age-related macular degeneration (AMD). The study confirms weak associations of APOE coding variants with AMD risk (P < 0.05) but finds no association with HMCN1 variants. Large replication studies of candidate genes TLR3 and SERPING1 (1,080-4,881 cases and 2,669-2,842 controls) show no association. The authors identified 15 high-risk variants in ARMS2/HTRA1 region on chromosome 10q23.33-10qter, with the ARMS2 A69S variant showing 2.7-fold increased risk heterozygously and 8.2-fold increased risk homozygously, comparable in strength to CFH Y402H. An indel variant (c.*372_815del443ins54) in ARMS2 3' UTR causes mRNA destabilization.

Traits studied:Age-related macular degeneration (AMD)Choroidal neovascularizationGeographic atrophy (GA)
No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese
AssociationN=251Norimoto Gotoh et al.(2006)· Human Genetics

A case-control study of 146 Japanese exudative age-related macular degeneration (ARMD) patients and 105 controls examined complement factor H (CFH) gene polymorphisms. The study identified 61 polymorphisms in the CFH gene but found no association between rs1061170 (Y402H, χ² = 3.19, P = 0.423) or other CFH variants and exudative ARMD in Japanese, despite this SNP showing strong association in Caucasians (χ² = 110.96, P < 10⁻²⁴). The absence of CFH association in Japanese may reflect ethnic differences in ARMD phenotypes and genetic architecture.

Traits studied:Age-related macular degeneration (ARMD)Choroidal neovascularization (CNV)Exudative ARMD

About CFH

This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]

View all CFH variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…